CytRx Corporation announced Joel Caldwell tendered his resignation as a Class III director in anticipation of being appointed a Class II director. On May 27, 2022, following Mr. Caldwell's resignation as a Class III director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -8.00% | -8.00% | +112.31% |
1st Jan change | Capi. | |
---|---|---|
+112.31% | 1.37M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- CytRx Corporation Announces Director Changes